Raffi Asadorian

Insider Reports History

Entity
Individual
Location
C/O Acelrx Pharmaceuticals, Inc., 351 Galveston Drive, Redwood City, CA
Signature
/s/ Martha Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raffi Asadorian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TALPHERA, INC. Chief Financial Officer Common Stock 47.2K $27.7K $0.59 Apr 2, 2025 Direct
TALPHERA, INC. Chief Financial Officer Stock Option (Right to Buy) 80K Apr 2, 2025 Direct

Insider Reports Filed by Raffi Asadorian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLPH TALPHERA, INC. Apr 2, 2025 2 $0 4 Apr 3, 2025 Chief Financial Officer
TLPH TALPHERA, INC. Feb 14, 2025 1 -$2.17K 4 Feb 18, 2025 Chief Financial Officer
TLPH TALPHERA, INC. Feb 10, 2025 2 -$1.32K 4 Feb 12, 2025 Chief Financial Officer
TLPH TALPHERA, INC. Dec 2, 2024 1 -$119 4 Dec 2, 2024 Chief Financial Officer
TLPH TALPHERA, INC. Mar 3, 2024 1 -$725 4 Mar 4, 2024 Chief Financial Officer
TLPH TALPHERA, INC. Feb 14, 2024 2 $0 4 Feb 27, 2024 Chief Financial Officer
TLPH TALPHERA, INC. Feb 10, 2024 2 -$1.97K 4 Feb 13, 2024 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Mar 3, 2023 1 -$668 4 Mar 6, 2023 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Feb 10, 2023 3 -$1.47K 4 Feb 14, 2023 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Feb 6, 2023 1 -$1.25K 4 Feb 8, 2023 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Mar 3, 2022 1 -$3.22K 4 Mar 4, 2022 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Feb 11, 2022 3 -$3.18K 4 Feb 14, 2022 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Feb 6, 2022 1 -$4.05K 4 Feb 7, 2022 Chief Financial Officer